Silicon Kidney LLC Profile last edited on: 11/8/2019
CAGE: 68M07
UEI: G6SHT3ZJ2LW6
Business Identifier: Bioartifical kidney development and biomedical applications of silicone membrane technology. 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 11
County: San Francisco
Congr. District: 11
County: San Francisco
Public Profile
Silicon Kidney LLC is a small biotechnology company focusing on the construction of implantable bioartifical kidneys using silicone membrane technology. The company's principal also has interests in testing this silicon membrane technology for other biomedical applications. The company aims to commercialize the silicone membrane technology developed as part of an artifical kidney project funded (beginning in 2015 via a $6 million grant) by NIH's National Institute of Biomedical Imaging and Bioengineering. The NIH grant was awarded to the laboratories of Dr. Shuvo Roy, a bioengineering professor at the University of California in San Francisco, and Dr. William Fissell, a nephrologist and engineer at Vanderbilt University. Roy and Fissell have ownership stakes in Silicon Kidney LLC.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
1-4Revenue Range
Less than .5MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
N/AAwards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 2023 | 2 | NIH | $2,264,126 | |
| Project Title: A Silicon Nanopore Membrane Blood Filter Enabling Anticoagulant Free Continuous Renal Replacement Therapy for Acute Kidney Injury | ||||
| 2019 | 2 | NIH | $1,668,917 | |
| Project Title: An Implantable Hemodialyzer for Treatment of End-Stage Renal Disease | ||||
| 2019 | 2 | NIH | $1,716,925 | |
| Project Title: An Intravascular Bioartificial Pancreas (IBAP) | ||||
| 2019 | 1 | NIH | $298,388 | |
| Project Title: A High Oxygen Capacity Cell Scaffold for the Intravascular Bioartifical Pancreas (IBAP) | ||||
| 2014 | 1 | NSF | $150,000 | |
| Project Title: A High-Efficiency and Compact Blood Filter for Enhanced Removal of Toxins During Hemodialysis | ||||
Key People / Management
Charles Blaha
William Fissell
Shuvo Roy
William Fissell
Shuvo Roy
Company News
There are no news available.
